Stress-activated Protein Kinases (JNK and p38/HOG) Are Essential for Vascular Endothelial Growth Factor mRNA Stability
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Stability of the vascular endothelial growth factor (VEGF) mRNA is tightly regulated through its 3'-untranslated region (3'-UTR). Here, we demonstrate that VEGF mRNA levels are increased by anisomycin, a strong activator of stress-activated protein kinases. Hence, VEGF mRNA induction is inhibited by SB202190, an inhibitor of JNK and p38/HOG kinase. Furthermore, VEGF mRNA expression is increased in cells that overexpress JNK and p38/HOG by an increase in its stability. We show by two different approaches that anisomycin exerts its effect on the VEGF mRNA 3'-UTR. First, by using an in vitro mRNA degradation assay, the half-life of the VEGF mRNA 3'-UTR region transcript was found to be increased when incubated with extracts from anisomycin-treated cells; and second, the 3'-UTR was also sufficient to confer mRNA instability to the Nhe3 (Na(+)/H(+) exchanger 3) heterologous reporter gene, and anisomycin treatment stabilized the chimeric mRNA (Nhe3 fused to the VEGF mRNA 3'-UTR). This chimeric mRNA is also more stable in cells overexpressing p38/HOG and JNK that have been stimulated by anisomycin. We show that such regulation is mediated through an AU-rich region of the 3'-UTR contained within a stable hairpin structure. By RNA electrophoretic mobility shift assays, we show that this region binds proteins specifically induced by anisomycin treatment. These findings clearly demonstrate a major role of stress-activated protein kinases in the post-transcriptional regulation of VEGF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“while overexpression of p38 and JNK also leads to VEGF expression elevation [ 51 ].”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risau, W. (1997) · Nature · doi:10.1038/386671a0 · Cited by 5,727
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian Cells
Han, J., Lee, J.-D., Bibbs, L., & Ulevitch, R. J. (1994) · Science · doi:10.1126/science.7914033 · Cited by 2,646
Mitogen-activated protein kinase pathways
Robinson, M. J., & Cobb, M. H. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80061-0 · Cited by 2,474
On Finding All Suboptimal Foldings of an RNA Molecule
Zuker, M. (1989) · Science · doi:10.1126/science.2468181 · Cited by 2,005
Independent Human MAP-Kinase Signal Transduction Pathways Defined by MEK and MKK Isoforms
Dérijard, B., Raingeaud, J., Barrett, T., Wu, I.-H., Han, J., Ulevitch, R. J., & Davis, R. J. (1995) · Science · doi:10.1126/science.7839144 · Cited by 1,555
How Proteolysis Drives the Cell Cycle
King, R. W., Deshaies, R. J., Peters, J.-M., & Kirschner, M. W. (1996) · Science · doi:10.1126/science.274.5293.1652 · Cited by 1,273
Ellis, L., Clauser, E., Morgan, D. O., Edery, M., Roth, R. A., & Rutter, W. J. (1986) · Cell · doi:10.1016/0092-8674(86)90786-5 · Cited by 1,070
Research works printed but not linked: 2
- Chen, 1994, Mol. Cell. Biol., 14, 8471
- Robinson, 1997, Curr. Opin. Oncol., 9, 180
Cited by
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232
Hypoxia signalling in cancer and approaches to enforce tumour regression
Pouysségur, J., Dayan, F., & Mazure, N. M. (2006) · Nature · doi:10.1038/nature04871 · Cited by 1,676
“Other levels of regulation of VEGF-A occur, including the stabilization of the mRNA through the stress-activated kinase p38 (ref”
BackgroundSelf-citationp38 MAP-Kinases pathway regulation, function and role in human diseases
Cuenda, A., & Rousseau, S. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.03.010 · Cited by 1,400
“Interestingly it is known that p38α is activated by hypoxia, a condition that leads to VEGF expression, which could also contribute to defective angiogenic signalling seen in p38α-deficient mice.”
BackgroundInfluentialRegulation of mRNA stability in mammalian cells
Guhaniyogi, J., & Brewer, G. (2001) · Gene · doi:10.1016/s0378-1119(01)00350-x · Cited by 729
TSC2 regulates VEGF through mTOR-dependent and -independent pathways
Brugarolas, J. B., Vazquez, F., Reddy, A., Sellers, W. R., & Kaelin, W. G. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00187-9 · Cited by 528
Bakheet, T. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.1.246 · Cited by 398
“Vascular endothelial growth factor (16)”
Li, D.-Q., Chen, Z., Song, X. J., Luo, L., & Pflugfelder, S. C. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0299 · Cited by 392
Neininger, A., Kontoyiannis, D., Kotlyarov, A., Winzen, R., Eckert, R., Volk, H.-D., Holtmann, H., Kollias, G., & Gaestel, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100685200 · Cited by 393
Lasa, M., Abraham, S. M., Boucheron, C., Saklatvala, J., & Clark, A. R. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.22.7802-7811.2002 · Cited by 382
Li, D.-Q., Luo, L., Chen, Z., Kim, H.-S., Song, X. J., & Pflugfelder, S. C. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2005.08.019 · Cited by 345
“SB202190, a chemical originally reported as a p38 MAPK pathway inhibitor, has also been recognized to inhibit JNK activation (Chen et al., 1998; Ming et al., 1998; Pages et al., 2000).”
BackgroundPost‐transcriptional regulation of gene expression by degradation of messenger RNAs
Bevilacqua, A., Ceriani, M. C., Capaccioli, S., & Nicolin, A. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10272 · Cited by 316
Dean, J. L. E., Sully, G., Clark, A. R., & Saklatvala, J. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2004.04.006 · Cited by 307
Benhar, M., Dalyot, I., Engelberg, D., & Levitzki, A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.20.6913-6926.2001 · Cited by 306
Identification of Two Sp1 Phosphorylation Sites for p42/p44 Mitogen-activated Protein Kinases
Milanini-Mongiat, J., Pouysségur, J., & Pagès, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201753200 · Cited by 287
Self-citationFrevel, M. A. E., Bakheet, T., Silva, A. M., Hissong, J. G., Khabar, K. S. A., & Williams, B. R. G. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.425-436.2003 · Cited by 288
“... p38 mitogen-activated protein kinase (MAP kinase) pathway has been implicated in the regulation of the mRNA half-lives of a number of AU-rich genes, including cyclooxygenase 2 (COX2), tumor necrosis factor alpha, interleukin-3, interleukin-6, interleukin-8, macrophage-inhibitory protein 1 (MIP1), granulocyte macro…”
BackgroundOuchi, N., Shibata, R., & Walsh, K. (2005) · Circulation Research · doi:10.1161/01.res.0000163633.10240.3b · Cited by 238
TRANSCRIPTIONAL AND POST-TRANSCRIPTIONAL CONTROL OF GENE EXPRESSION IN INFLAMMATION
Kracht, M., & Saklatvala, J. (2002) · Cytokine · doi:10.1006/cyto.2002.0895 · Cited by 229
MAP Kinases and Hypoxia in the Control of VEGF Expression
Berra, E., Pagès, G., & Pouysségur, J. (2000) · Cancer and Metastasis Reviews · doi:10.1023/a:1026506011458 · Cited by 223
Self-citationCok, S. J., & Morrison, A. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008461200 · Cited by 214
AMP-Activated Kinase Regulates Cytoplasmic HuR
Wang, W., Fan, J., Yang, X., Fürer-Galban, S., Lopez de Silanes, I., von Kobbe, C., Guo, J., Georas, S. N., Foufelle, F., Hardie, D. G., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.10.3425-3436.2002 · Cited by 208
“Another MAPK, p38, was shown to participate in the stabilization of mRNAs encoding IL-8, c-fos, granulocyte-macrophage colonystimulating factor, TNF-, VEGF, and cyclo-oxygenase 2 (10, 32, 45 , 58).”
BackgroundPost-transcriptional and Nongenomic Effects of Glucocorticoids
Stellato, C. (2004) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200402-015ms · Cited by 196
“Activation of JNK/SAPK signaling induced ARE-dependent mRNA stabilization of IL-3 and vascular endothelial growth factor (VEGF) mRNAs (37, 38), whereas in activated T lymphocytes, stabilization of IL-2 mRNA was conferred by a JNKresponsive element present in the 5 -UTR (4).”
BackgroundPost‐transcriptional regulation of gene expression by mitogen‐activated protein kinase p38
Clark, A. R., Dean, J. L. E., & Saklatvala, J. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00439-3 · Cited by 196
PGE2 Stimulates VEGF Expression in Endothelial Cells via ERK2/JNK1 Signaling Pathways
Pai, R., Szabo, I. L., Soreghan, B. A., Atay, S., Kawanaka, H., & Tarnawski, A. S. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5494 · Cited by 195
Regulation of Vascular Endothelial Growth Factor Expression by Advanced Glycation End Products
Treins, C., Giorgetti-Peraldi, S., Murdaca, J., & Van Obberghen, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106534200 · Cited by 191
The AU-Rich Transcriptome: More Than Interferons and Cytokines, and Its Role in Disease
Khabar, K. S. A. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.1 · Cited by 174
“(52) AUF1 binds to and destabilizes ARE mRNAs, such as those of c-myc, GM-CSF, and others, (5,18,43,53) but, in contrast, can stabilize specific ARE mRNAs during heat shock.”
Stimulation of angiogenesis by Ras proteins
Kranenburg, O., Gebbink, M. F. B. G., & Voest, E. E. (2004) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2003.09.004 · Cited by 168
Modulation of mRNA stability as a novel therapeutic approach
Eberhardt, W., Doller, A., Akool, E.-S., & Pfeilschifter, J. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.01.002 · Cited by 173
Pereira, E. R., Liao, N., Neale, G. A. M., & Hendershot, L. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012521 · Cited by 177
“Additionally, stress activated protein kinases such as AMPK, p38MAPK, JNK, and PI3K have been implicated in increasing VEGFA mRNA stability through their action on the AU rich region of the 3’UTR [40,41,42,43].”
BackgroundConstitutive and inducible expression and regulation of vascular endothelial growth factor
Xie, K., Wei, D., Shi, Q., & Huang, S. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.04.003 · Cited by 163
“Although the detailed signaling pathway remains unclear, the stress-activated protein kinases c-jun N-terminal kinase (JNK) and p38/HOG appear to be indispensable for the stabilization of VEGF mRNA [117].”
BackgroundKempf, V. A. J., Lebiedziejewski, M., Alitalo, K., Wälzlein, J.-H., Ehehalt, U., Fiebig, J., Huber, S., Schütt, B., Sander, C. A., Müller, S., et al. (2005) · Circulation · doi:10.1161/01.cir.0000155608.07691.b7 · Cited by 164
Cytokine Regulation of Facilitated Glucose Transport in Human Articular Chondrocytes
Shikhman, A. R., Brinson, D. C., Valbracht, J., & Lotz, M. K. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.12.7001 · Cited by 157
Post-transcriptional control during chronic inflammation and cancer: a focus on AU-rich elements
Khabar, K. S. A. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0383-x · Cited by 157
Kim, H.-S., Luo, L., Pflugfelder, S. C., & Li, D.-Q. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0929 · Cited by 146
“SB202190 showed stronger inhibition of TGF- 1–induced MMP-9 than did SP600125 and PD98059, perhaps because SB202190 at 20 M inhibits both the p38 and JNK pathways.(31,32) Doxycycline, at 5 to 40 g/mL, concentration dependently inhibited the TGF- 1–ed production of MMP-9 (Fig.”
BackgroundMAP kinase phosphatase 1: a novel mediator of biological effects of glucocorticoids?
Clark, A. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1780005 · Cited by 147
Yun, H., Lee, M., Kim, S.-S., & Ha, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412994200 · Cited by 143
RetractedMechanisms of Disease: angiogenesis and the management of breast cancer
Banerjee, S. N., Dowsett, M., Ashworth, A., & Martin, L. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0905 · Cited by 156
“VEGF mRNA stability is influenced by the stress-activated kinase p38”
BackgroundBatlle, R., Andrés, E., Gonzalez, L., Llonch, E., Igea, A., Gutierrez-Prat, N., Berenguer-Llergo, A., & Nebreda, A. R. (2019) · Nature Communications · doi:10.1038/s41467-019-10946-y · Cited by 142
Stabilization of Vascular Endothelial Growth Factor mRNA by Hypoxia-Inducible Factor 1
Liu, L. X., Lu, H., Luo, Y., Date, T., Belanger, A. J., Vincent, K. A., Akita, G. Y., Goldberg, M. A., Cheng, S. H., Gregory, R. J., et al. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6551 · Cited by 145
Destabilization of vascular endothelial growth factor mRNA by the zinc-finger protein TIS11b
Ciais, D., Cherradi, N., Bailly, S., Grenier, E., Berra, E., Pouysségur, J., LaMarre, J., & Feige, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207939 · Cited by 132
“Interestingly, this TBE sequence has previously been shown to be involved in the stabilization of VEGF mRNA after JNK and p38/HOG activation (Pages et al., 2000).”
BackgroundSelf-citationPGC-1α mediates exercise-induced skeletal muscle VEGF expression in mice
Leick, L., Hellsten, Y., Fentz, J., Lyngby, S. S., Wojtaszewski, J. F. P., Hidalgo, J., & Pilegaard, H. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00076.2009 · Cited by 125
The Control of mRNA Stability in Response to Extracellular Stimuli
Shim, J., & Karin, M. (2002) · Molecules and Cells · doi:10.1016/s1016-8478(23)15111-9 · Cited by 121
“A recent study demonstrated that hypoxia-induced stabilization of VEGF mRNA is mediated through the activation of stress-activated protein kinases like JNK and p38 (Pages et al., 2000).”
BackgroundJak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma
Krejsgaard, T., Vetter‐Kauczok, C. S., Woetmann, A., Lovato, P., Labuda, T., Eriksen, K., Zhang, Q., Becker, J. C., & Ødum, N. (2006) · Leukemia · doi:10.1038/sj.leu.2404350 · Cited by 116
Post-Transcriptional Control of the Hypoxic Response by RNA-Binding Proteins and MicroRNAs
Gorospe, M., Tominaga, K., Wu, X., Fähling, M., & Ivan, M. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00007 · Cited by 109
“The VEGF mRNA is highly unstable in normoxia, but its half-life increases rapidly in response to cytokines and stress conditions such as hypoxia (Levy et al., 1998; Pagès et al., 2000).”
Inhibitory effects of isoliquiritigenin on the migration and invasion of human breast cancer cells
Wang, K.-L., Hsia, S., Chan, C.-J., Chang, F.-Y., Huang, C., Bau, D., & Wang, P. S. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.756869 · Cited by 111
“Furthermore, stress-induced p38 is responsible for the stability of VEGF mRNA [53].”
BackgroundEssafi-Benkhadir, K., Onesto, C., Stebe, E., Moroni, C., & Pagès, G. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-06-0570 · Cited by 101
“The Luc-HP construct, which contains five AU consensus domains that form a stable hairpin structure important for the posttranscriptional regulation of VEGF (Pagès et al., 2000), similarly responded to TTP, although slightly less than the full-length construct.”
BackgroundSelf-citationCurry, J. M., Eubank, T. D., Roberts, R. D., Wang, Y., Pore, N., Maity, A. M., & Marsh, C. B. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003405 · Cited by 112
“In addition to inducing VEGF production from monocytes, M-CSF is also known to stimulate the production of other pro-angiogenic factors, such as IL-8 [38] and MMP-9 [43].”
BackgroundThe p38 mitogen-activated protein kinase signaling cascade in CD4 T cells.
Dodeller, F., & Schulze‐Koops, H. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1905 · Cited by 116
“The p38 MAPK pathway has been shown to affect the mRNA stability of proinflammatory genes, mainly that of mRNA for cytokines such as IL-2, IL-3, IL-6, IL-8, TNF, and GM-CSF [90-92] but also that of mRNA for cyclo-oxygenase 2 (COX2) [93], vascular endothelial growth factor (VEGF) [94], macrophage inflammatory protein 2…”
BackgroundWu, Y., Zhang, Q., Ann, D. K., Akhondzadeh, A., Duong, H. S., Messadi, D. V., & Le, A. D. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00200.2003 · Cited by 103
“Transcriptional activation of VEGF expression is mediated by the active HIF-1 via its binding to the consensus hypoxiaresponsive elements (HRE) in the promoter of VEGF (18, 24, 35), whereas hypoxia-induced increase in message stability is likely conferred by RNA-binding proteins (34, 43, 53).”
BackgroundWasserman, T., Cohen‐Katsenelson, K., Daniliuc, S., Hasin, T., Choder, M., & Aronheim, A. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-06-0512 · Cited by 109
Molecular Pathways: Mitogen-Activated Protein Kinase Pathway Mutations and Drug Resistance
Pritchard, A. L., & Hayward, N. K. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0383 · Cited by 112
Coles, L. S., Bartley, M. A., Bert, A., Hunter, J., Polyak, S., Diamond, P., Vadas, M. A., & Goodall, G. J. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2003.03968.x · Cited by 93
Solban, N., Selbo, P. K., Alok, S. K., Sung, C. K., & Hasan, T. G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0604 · Cited by 95
Minet, E., Michel, G., Mottet, D., Piret, J., Barbieux, A., Raes, M. J., & Michiels, C. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5180 · Cited by 101
The Core Promoter of Human Thioredoxin Reductase 1
Rundlöf, A.-K., Carlsten, M., & Arnér, E. S. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101452200 · Cited by 89
Lahti, A., Jalonen, U., Kankaanranta, H., & Moilanen, E. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.2.308 · Cited by 96
“Previously, JNK has been shown to participate in the stabilization of mRNAs of vascular endothelial growth factor, IL-2, and IL-3 (Chen et al., 1998; Ming et al., 1998; Pages et al., 2000).”
BackgroundFoster, G. H., & Tesh, V. L. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.1.107 · Cited by 92
Grabiec, A. M., Angiolilli, C., Hartkamp, L. M., van Baarsen, L. G. M., Tak, P. P., & Reedquist, K. A. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203610 · Cited by 84
Khandrika, L., Lieberman, R., Koul, S., Kumar, B., MARONI, P. D., Chandhoke, R. A., Meacham, R. B., & Koul, H. K. (2009) · Oncogene · doi:10.1038/onc.2008.476 · Cited by 94
“Though p38 MAPK has not been directly implicated with increased transcription of VEGF, many studies suggest the involvement of p38 MAPK in increased VEGF levels during hypoxia (Murata et al., 2006; Yoshino et al., 2006) probably by increasing mRNA stability (Pagès et al., 2000).”
BackgroundRetractedOnesto, C., Berra, E., Grépin, R., & Pagès, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400219200 · Cited by 75
Self-citationDuyndam, M. C. A., Hulscher, S. T. M., van der Wall, E., Pinedo, H. M., & Boven, E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206320200 · Cited by 87
Guma, M., Rius, J., Duong-Polk, K. X., Haddad, G. G., Lindsey, J. D., & Karin, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902659106 · Cited by 80
“In cell culture studies, a nonspecific JNK inhibitor was shown to affect VEGF mRNA stabilization (12).”
BackgroundRNA‐binding proteins implicated in the hypoxic response
Masuda, K., Abdelmohsen, K., & Gorospe, M. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00842.x · Cited by 84
“VEGF is extensively regulated by mRNA stabilization; the VEGF mRNA is highly unstable in normoxia, but its half-life increases rapidly in response to cytokines and stress conditions such as hypoxia [68–71].”
Backgroundde Oliveira, A. C. P., Candelario‐Jalil, E., Bhatia, H. S., Lieb, K., Hüll, M., & Fiebich, B. L. (2008) · Glia · doi:10.1002/glia.20658 · Cited by 88
“In addition to regulate mPGES-1 mRNA stability, JNK enzymes may also participate in the regulation of mPGES-1 mRNA translation and/or the regulation of mPGES-1 protein stability, as JNK enzymes have been shown to stabilize many proteins (Kim et al., 2002; Pages et al., 2000; Toh et al., 2004).”
BackgroundYao, H., Wang, H., Zhang, Z., Jiang, B., Luo, J., & Shi, X. (2008) · International Journal of Cancer · doi:10.1002/ijc.23647 · Cited by 80
Mechanisms underlying PTEN regulation of vascular endothelial growth factor and angiogenesis
Gomez‐Manzano, C., Fueyo, J., Jiang, H., Glass, T. L., Lee, H., Hu, M., Liu, J., Jasti, S. L., Liu, T., Conrad, C. A., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10396 · Cited by 78
“Because other reports indicated that VEGF expression is regulated either by the p42/p44 mitogenactivated protein (MAP) kinase pathway or by p38 MAP kinase, these two pathways also were examined in the two human gliomas cell lines.(30,31) The activities of these MAP proteins were measured by kinase assays based on the…”
MethodBasic Science Review: Current Insights on the Biology and Clinical Aspects of VEGF Regulation
Birk, D. M., Barbato, J. E., Mureebe, L., & Chaer, R. A. (2008) · Vascular and Endovascular Surgery · doi:10.1177/1538574408322755 · Cited by 89
Role of VEGF/VEGFR in the pathogenesis of leukemias and as treatment targets (Review)
Song, G., Li, Y., & Jiang, G. (2012) · Oncology Reports · doi:10.3892/or.2012.2045 · Cited by 75
“However, the JNKs have been shown to promote VEGF expression through other mechanisms, such as increasing VEGF mRNA stability (32).”
Targeting MAPK Signaling in Age-Related Macular Degeneration
Kyosseva, S. V. (2016) · Ophthalmology and Eye Diseases · doi:10.4137/oed.s32200 · Cited by 74
Klettner, A., & Roider, J. (2009) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-009-1139-x · Cited by 74
“In RPE cells, JNK and p38 have an important role in stabilizing VEGF mRNA [9]; and the insulin-like-growth factor (IGF-1)-induced VEGF expression is dependent on JNK [10].”
BackgroundLin, H., Lai, S.-C., & Chau, L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.168831 · Cited by 76
Spiegelman, V. S., Stavropoulos, P., Latres, E., Pagano, M., Ronai, Z. A., Slaga, T. J., & Fuchs, S. Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100031200 · Cited by 75
Integrin α3β1 as a breast cancer target
Subbaram, S., & DiPersio, C. M. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.609557 · Cited by 75
“Given the roles that the FAK/Src signaling axis is likely to play in breast cancer growth and malignant progression (reviewed in [16,17] and discussed above in Section 1.1), it is significant that integrin a3b1 can stimulate FAK in mammary epithelial cells or other epithelial cells [19,20,104], especially since FAK si…”
BackgroundInfluentialCao, J., Cetrulo, C. L., & Theoharides, T. C. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.019539 · Cited by 82
“It was shown that activation of the p38 MAPK increased the stability of the VEGF mRNA in some cell types, an action presumably mediated through the AU-rich region of its 3’ untranslated region (Pages et al., 2000).”
BackgroundRegulation of CD40 ligand expression in systemic lupus erythematosus
Crow, M. K., & Kirou, K. A. (2001) · Current Opinion in Rheumatology · doi:10.1097/00002281-200109000-00004 · Cited by 68
Hippocampal c-Jun-N-Terminal Kinases Serve as Negative Regulators of Associative Learning
Sherrin, T., Blank, T., Hippel, C., Rayner, M. D., Davis, R. J., & Todorovic, C. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3492-10.2010 · Cited by 75
“We have used anisomycin as a potent agonist of JNK (Cano et al., 1994; Hazzalin et al., 1998; Pagès et al., 2000), and with such an approach, we corroborated our findings that both exposure to acute stress and activation of septal CRF2 receptors results in hippocampal JNK activation, which, in turns, leads to an impai…”
ResultMicroenvironment Changes (in pH) Affect VEGF Alternative Splicing
Elias, A. P., & Dias, S. (2008) · Cancer Microenvironment · doi:10.1007/s12307-008-0013-4 · Cited by 64
“[22] demonstrated that anisomycin (a strong activator of stress-activated protein kinases, SAPKs) increased VEGF mRNA stabilization through the activation of p38 kinase and JNK.”
BackgroundMAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges
Moustardas, P., Aberdam, D., & Lagali, N. (2023) · Cells · doi:10.3390/cells12040617 · Cited by 63
Mazumder, B., Seshadri, V., Imataka, H., Sonenberg, N., & Fox, P. L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.19.6440-6449.2001 · Cited by 61
“For example, mRNA stability is regulated by the interaction of specific trans-acting RNA-binding proteins to cognate cis-acting sequences in the 3 -UTR of tumor necrosis factor alpha (22, 36), vascular endothelial growth factor (35, 46), inducible nitric oxide synthase (40), elastin (15), and the transferrin receptor…”
BackgroundVolpi, G., Facchinetti, F., Moretto, N., Civelli, M., & Patacchini, R. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01253.x · Cited by 60
“Intracellular signalling pathways such as p38 MAPK and ERK1/2 have been shown to modulate VEGF expression in various cell types including human vascular smooth muscle cells (Pagès et al., 2000a,b).”
BackgroundResultPeroxynitrite increases VEGF expression in vascular endothelial cells via STAT3
Platt, D. H., Bartoli, M., El‐Remessy, A. B., Al‐Shabrawey, M., Lemtalsi, T., Fulton, D. J., & Caldwell, R. B. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.06.015 · Cited by 65
Post-transcriptional gene regulation by MAP kinases via AU-rich elements
Clark, A. (2009) · Frontiers in Bioscience · doi:10.2741/3282 · Cited by 60
Klettner, A., Westhues, D., Lassen, J. F., Bartsch, S., & Roider, J. B. (2013) · PubMed Central · Cited by 69
Triamcinolone Acetonide Destabilizes VEGF mRNA in Müller Cells under Continuous Cobalt Stimulation
Sears, J. E., & Hoppe, G. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0565 · Cited by 63
“The VEGF 3 UTR contains nine copies of the nonameric consensus sequence for adenylate/uridate-rich (ARE) elements.(5) Three proteins have been identified that bind and stabilize VEGF transcripts with specific affinity for the 3 UTR, HuC, a member of the ELAV family,(6) the ribonucleoprotein hnRNPL,(7) and poly(A)-bind…”
BackgroundGille, J., Reisinger, K., Westphal-Varghese, B., & Kaufmann, R. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01573.x · Cited by 57
Involvement of p38 MAP kinase in TGF‐β‐stimulated VEGF synthesis in aortic smooth muscle cells
Yamamoto, T., Kozawa, O., Tanabe, K., Akamatsu, S., Matsuno, H., Dohi, S., & Uematsu, T. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1179 · Cited by 55
“A recent publication indicated that anisomycin, strong activator of the p38 MAP kinase and JNK, increases VEGF mRNA stabilization through the activation of p38 MAP kinase and JNK in hamster ®broblast's derivatives [Pages et al., 2000].”
BackgroundThrombin-Induced VEGF Expression in Human Retinal Pigment Epithelial Cells
Bian, Z.-M., Elner, S. G., & Elner, V. M. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-1023 · Cited by 58
Korhonen, R., Linker, K., Pautz, A., Förstermann, U., Moilanen, E., & Kleinert, H. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.033449 · Cited by 60
“Using dominant-negative isoforms or over-expressing JNK it has been shown that JNK regulates the stability of IL-3 mRNA and vascular endothelial growth factor mRNA by a 3 -UTR-dependent mechanism (Ming et al., 1998; Pages et al., 2000).”
BackgroundTerasaki, H., Kase, S., Shirasawa, M., Otsuka, H., Hisatomi, T., Sonoda, S., Ishida, S., Ishibashi, T., & Sakamoto, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069994 · Cited by 55
“The JNK and NF-kB pathways play important roles in the secretion of VEGF [16,17,21,34,39,40,41], and a crosstalk between the JNK and NF-kB pathways is a major determinant of the fate of cells where NF-kB inhibits the activation of JNK [35,37,38].”
BackgroundsHsp-Phosphorylation: Enzymes, Signaling Pathways and Functional Implications
Gaestel, M. (2002) · Progress in molecular and subcellular biology · doi:10.1007/978-3-642-56348-5_8 · Cited by 57
Therapeutic effect of c‐Jun N‐terminal kinase inhibition on pancreatic cancer
Takahashi, R., Hirata, Y., Sakitani, K., Nakata, W., Kinoshita, H., Hayakawa, Y., Nakagawa, H., Sakamoto, K., Hikiba, Y., Ijichi, H., et al. (2012) · Cancer Science · doi:10.1111/cas.12080 · Cited by 51
Cook‐Andersen, H., Mischo, H. E., & STEITZ, J. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.10.4522-4533.2004 · Cited by 51
Nieminen, R. M., Lahti, A., Jalonen, U., Kankaanranta, H., & Moilanen, E. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.01.009 · Cited by 54
Pratt, P. F., Bokemeyer, D., Foschi, M., Sorokin, A., & Dunn, M. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309256200 · Cited by 45
Onguchi, T., Han, K., Chang, J., & Azar, D. T. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080452 · Cited by 43
“Activation of MAP kinases by various cellular stresses increases VEGF mRNA stability and subsequently enhances VEGF protein production.(42) These findings and reports imply a mechanism of MT1-MMP modulating bFGF signal transduction pathways and subsequently regulating VEGF-A expression.”
BackgroundStress kinase signaling in cancer: fact or fiction?
Rennefahrt, U. E. E., Janakiraman, M., Öllinger, R., & Troppmair, J. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.08.003 · Cited by 43
“[88] G.”
BackgroundZhang, J., Ge, P., Liu, J., Luo, Y., Guo, H., Zhang, G., Xu, C., & Chen, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512138 · Cited by 47
Chinn, A. M. (2002) · Molecular Endocrinology · doi:10.1210/me.16.6.1417 · Cited by 39
Krupiński, J., SLEVIN, M. A., Martí, E., Catena, E., Rubio, F. J., & Gaffney, J. J. (2003) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2003.00454.x · Cited by 39
Marengo, B., Ciucis, C. G. D., Ricciarelli, R., Furfaro, A. L., Colla, R., Canepa, E., Traverso, N., Marinari, U. M., Pronzato, M. A., & Domenicotti, C. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.118 · Cited by 40
Yeh, Y., Hou, M., Chung, Y., Chen, Y., Yang, S., Chen, D., Su, J., & Yuan, S. F. (2005) · International Journal of Cancer · doi:10.1002/ijc.21707 · Cited by 37
“Moreover, activated JNK and p38 are both able to increase the stability of VEGF mRNA and thus support tumor growth.(34) There is little information available whether the crosstalk/correlation between the activated MAPKs is present in human cancers, in vivo.”
Background
Metadata
- Authors
- Pagès, G., Berra, E., Milanini, J., Levy, A. P., & Pouysségur, J.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Technion – Israel Institute of Technology (IL)
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-08
- Volume
- 275
- Issue
- 34
- Pages
- 26484-26491
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2003506860
- Cited by
- 184
- References
- 52
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 4 · 2022: 2 · 2021: 2 · 2019: 1 · 2018: 2 · 2017: 5 · 2016: 1 · 2015: 4 · 2014: 3 · 2013: 9 · 2012: 7
- FWCI
- 6.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 7373 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Kementerian Pendidikan Nasional
- Centre National de la Recherche Scientifique
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Keywords
- vascular endothelial growth factor, mRNA stability, 3' untranslated region, c-Jun N-terminal kinase, JNK, AU-rich region, AU-rich element-binding proteins, post-transcriptional regulation, anisomycin, mRNA degradation, hairpin structure
- MeSH terms
- Anisomycin, Enzyme Inhibitors, HeLa Cells, Humans, Imidazoles, Lymphokines, Nucleic Acid Conformation, Protein Synthesis Inhibitors, Pyridines, RNA, Messenger, Endothelial Growth Factors, Mitogen-Activated Protein Kinases, Saccharomyces cerevisiae Proteins, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, JNK Mitogen-Activated Protein Kinases, p38 Mitogen-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.